Bond™ PA0989-X
by Leica Biosystems Newcastle, Limited
Bond PA0989-X is a MSH2 antigen IVD (FDA Class I; FDA product code NJT, Immunohistochemistry Reagents And Kits) made by Leica Biosystems Newcastle, Limited, listed in FDA GUDID since 16 Dec 2022 (UDI-DI 05055331336736), registry data as of 22 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number05055331336736 | Date16 Dec 2022 | StatusListed |
Official records
- AccessGUDID record 05055331336736
From the FDA record
- Device description
- MSH2 (Mismatch Repair Protein) (79H11) monoclonal antibody is intended to be used for the qualitative identification by light microscopy of human MutS Homolog 2 (MSH2) protein in formalin-fixed, paraffin-embedded tissue by immunohistochemical staining using the automated BOND system (includes BOND-MAX and BOND-III systems). The clinical interpretation of any staining or its absence should be complemented by morphological studies and proper controls and should be evaluated within the context of the patient’s clinical history and other diagnostic tests by a qualified pathologist.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Bond™
- Generic name
- MSH2 antigen IVD, antibody
- Model / Ref / Catalog
- PA0989-X
- Primary DI / UDI-DI
- 05055331336736
- FDA product code
- NJT
- GMDN term
- MSH2 antigen IVD, antibody
- Device class
- Class I
- Regulation number
- 864.1860
- GUDID distribution status
- In Commercial Distribution
Similar devices in this category
Other devices filed under MSH2 antigen IVD, antibody.